
BCLI Valuation
Brainstorm Cell Therapeutics Inc
- Overview
- Forecast
- Valuation
- Earnings
BCLI Relative Valuation
BCLI's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, BCLI is overvalued; if below, it's undervalued.
Historical Valuation
Brainstorm Cell Therapeutics Inc (BCLI) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -4.27. The fair price of Brainstorm Cell Therapeutics Inc (BCLI) is between NaN to NaN according to relative valuation methord.
Relative Value
Fair Zone
NaN-NaN
Current Price:0.67
Fair
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
-1.27
P/B
Median3y
-0.58
Median5y
3.51
-64.89
FCF Yield
Median3y
-75.98
Median5y
-53.23
Competitors Valuation Multiple
The average P/S ratio for BCLI's competitors is 18.79, providing a benchmark for relative valuation. Brainstorm Cell Therapeutics Inc Corp (BCLI) exhibits a P/S ratio of , which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
People Also Watch

ICU
SeaStar Medical Holding Corp
0.771
USD
-1.03%

ZONE
CleanCore Solutions Inc
3.660
USD
-8.50%

APLM
Apollomics Inc
6.230
USD
+1.30%

AYTU
Aytu Biopharma Inc
2.625
USD
-0.94%

RDIB
Reading International Inc
10.300
USD
+1.78%

MSN
Emerson Radio Corp
0.430
USD
0.00%

MYNZ
Mainz Biomed NV
2.040
USD
+2.51%

QTI
QT Imaging Holdings Inc
0.395
USD
0.00%

BIAF
bioAffinity Technologies Inc
0.334
USD
-3.75%

SGMA
SigmaTron International Inc
3.010
USD
-0.33%
FAQ

Is Brainstorm Cell Therapeutics Inc (BCLI) currently overvalued or undervalued?
Brainstorm Cell Therapeutics Inc (BCLI) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -4.27. The fair price of Brainstorm Cell Therapeutics Inc (BCLI) is between NaN to NaN according to relative valuation methord.

What is Brainstorm Cell Therapeutics Inc (BCLI) fair value?

How does BCLI's valuation metrics compare to the industry average?

What is the current P/B ratio for Brainstorm Cell Therapeutics Inc (BCLI) as of Jul 26 2025?

What is the current FCF Yield for Brainstorm Cell Therapeutics Inc (BCLI) as of Jul 26 2025?

What is the current Forward P/E ratio for Brainstorm Cell Therapeutics Inc (BCLI) as of Jul 26 2025?
